nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—ulcerative colitis	0.249	0.586	CbGaD
Minocycline—MMP9—ulcerative colitis	0.176	0.414	CbGaD
Minocycline—ALOX5—Olsalazine—ulcerative colitis	0.134	0.318	CbGbCtD
Minocycline—ALOX5—Balsalazide—ulcerative colitis	0.119	0.284	CbGbCtD
Minocycline—ALOX5—Mesalazine—ulcerative colitis	0.0953	0.227	CbGbCtD
Minocycline—ALOX5—Sulfasalazine—ulcerative colitis	0.0533	0.127	CbGbCtD
Minocycline—SLC22A8—Mercaptopurine—ulcerative colitis	0.0185	0.044	CbGbCtD
Minocycline—CASP1—epithelium—ulcerative colitis	0.00194	0.0528	CbGeAlD
Minocycline—CYCS—epithelium—ulcerative colitis	0.00187	0.0508	CbGeAlD
Minocycline—CYCS—smooth muscle tissue—ulcerative colitis	0.0018	0.049	CbGeAlD
Minocycline—CASP3—epithelium—ulcerative colitis	0.0016	0.0435	CbGeAlD
Minocycline—CASP3—smooth muscle tissue—ulcerative colitis	0.00154	0.0419	CbGeAlD
Minocycline—CASP1—lymphoid tissue—ulcerative colitis	0.0015	0.0407	CbGeAlD
Minocycline—CASP1—digestive system—ulcerative colitis	0.00148	0.0402	CbGeAlD
Minocycline—CYCS—lymphoid tissue—ulcerative colitis	0.00144	0.0391	CbGeAlD
Minocycline—CYCS—digestive system—ulcerative colitis	0.00142	0.0387	CbGeAlD
Minocycline—IL1B—epithelium—ulcerative colitis	0.00128	0.0348	CbGeAlD
Minocycline—CASP3—lymphoid tissue—ulcerative colitis	0.00123	0.0335	CbGeAlD
Minocycline—IL1B—smooth muscle tissue—ulcerative colitis	0.00123	0.0335	CbGeAlD
Minocycline—CASP3—digestive system—ulcerative colitis	0.00122	0.0331	CbGeAlD
Minocycline—VEGFA—smooth muscle tissue—ulcerative colitis	0.00121	0.033	CbGeAlD
Minocycline—Doxycycline—MMP1—ulcerative colitis	0.00117	0.663	CrCbGaD
Minocycline—CASP1—liver—ulcerative colitis	0.0011	0.0299	CbGeAlD
Minocycline—MMP9—epithelium—ulcerative colitis	0.00107	0.029	CbGeAlD
Minocycline—CYCS—liver—ulcerative colitis	0.00106	0.0288	CbGeAlD
Minocycline—MMP9—smooth muscle tissue—ulcerative colitis	0.00103	0.0279	CbGeAlD
Minocycline—IL1B—lymphoid tissue—ulcerative colitis	0.000986	0.0268	CbGeAlD
Minocycline—IL1B—digestive system—ulcerative colitis	0.000974	0.0265	CbGeAlD
Minocycline—CASP3—liver—ulcerative colitis	0.000909	0.0247	CbGeAlD
Minocycline—MMP9—lymphoid tissue—ulcerative colitis	0.000822	0.0223	CbGeAlD
Minocycline—ALOX5—smooth muscle tissue—ulcerative colitis	0.000813	0.0221	CbGeAlD
Minocycline—MMP9—digestive system—ulcerative colitis	0.000812	0.022	CbGeAlD
Minocycline—SLC22A11—digestive system—ulcerative colitis	0.00077	0.0209	CbGeAlD
Minocycline—SLC22A7—digestive system—ulcerative colitis	0.000751	0.0204	CbGeAlD
Minocycline—IL1B—liver—ulcerative colitis	0.000726	0.0197	CbGeAlD
Minocycline—VEGFA—liver—ulcerative colitis	0.000714	0.0194	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—ulcerative colitis	0.00065	0.0176	CbGeAlD
Minocycline—ALOX5—digestive system—ulcerative colitis	0.000642	0.0174	CbGeAlD
Minocycline—MMP9—liver—ulcerative colitis	0.000605	0.0164	CbGeAlD
Minocycline—SLC22A11—liver—ulcerative colitis	0.000573	0.0156	CbGeAlD
Minocycline—SLC22A7—liver—ulcerative colitis	0.00056	0.0152	CbGeAlD
Minocycline—ALOX5—liver—ulcerative colitis	0.000478	0.013	CbGeAlD
Minocycline—Methacycline—ALB—ulcerative colitis	0.000415	0.234	CrCbGaD
Minocycline—IL1B—Methylprednisolone—Budesonide—ulcerative colitis	0.000289	0.0893	CbGdCrCtD
Minocycline—Tetracycline—ALB—ulcerative colitis	0.000182	0.103	CrCbGaD
Minocycline—IL1B—Fluorometholone—Budesonide—ulcerative colitis	0.000179	0.0554	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Hydrocortisone—ulcerative colitis	0.000148	0.0457	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Dexamethasone—ulcerative colitis	0.000137	0.0425	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Betamethasone—ulcerative colitis	0.000137	0.0425	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Triamcinolone—ulcerative colitis	0.000134	0.0415	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Prednisone—ulcerative colitis	0.000127	0.0394	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Prednisolone—ulcerative colitis	0.000124	0.0384	CbGdCrCtD
Minocycline—CYCS—Methyldopa—Mesalazine—ulcerative colitis	0.000104	0.032	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Hydrocortisone—ulcerative colitis	9.17e-05	0.0283	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Methylprednisolone—ulcerative colitis	8.66e-05	0.0267	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Betamethasone—ulcerative colitis	8.52e-05	0.0263	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Dexamethasone—ulcerative colitis	8.52e-05	0.0263	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Triamcinolone—ulcerative colitis	8.32e-05	0.0257	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Prednisone—ulcerative colitis	7.9e-05	0.0244	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Prednisolone—ulcerative colitis	7.71e-05	0.0238	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Budesonide—ulcerative colitis	7.32e-05	0.0226	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Budesonide—ulcerative colitis	7.32e-05	0.0226	CbGdCrCtD
Minocycline—IL1B—Budesonide—Hydrocortisone—ulcerative colitis	6.13e-05	0.0189	CbGdCrCtD
Minocycline—IL1B—Budesonide—Methylprednisolone—ulcerative colitis	5.78e-05	0.0179	CbGdCrCtD
Minocycline—IL1B—Budesonide—Dexamethasone—ulcerative colitis	5.69e-05	0.0176	CbGdCrCtD
Minocycline—IL1B—Budesonide—Betamethasone—ulcerative colitis	5.69e-05	0.0176	CbGdCrCtD
Minocycline—IL1B—Budesonide—Triamcinolone—ulcerative colitis	5.56e-05	0.0172	CbGdCrCtD
Minocycline—IL1B—Budesonide—Prednisone—ulcerative colitis	5.27e-05	0.0163	CbGdCrCtD
Minocycline—IL1B—Budesonide—Prednisolone—ulcerative colitis	5.15e-05	0.0159	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Budesonide—ulcerative colitis	3.91e-05	0.0121	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Budesonide—ulcerative colitis	3.91e-05	0.0121	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Hydrocortisone—ulcerative colitis	3.75e-05	0.0116	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Hydrocortisone—ulcerative colitis	3.75e-05	0.0116	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Methylprednisolone—ulcerative colitis	3.54e-05	0.0109	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Methylprednisolone—ulcerative colitis	3.54e-05	0.0109	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Dexamethasone—ulcerative colitis	3.48e-05	0.0108	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Betamethasone—ulcerative colitis	3.48e-05	0.0108	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Triamcinolone—ulcerative colitis	3.4e-05	0.0105	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Triamcinolone—ulcerative colitis	3.4e-05	0.0105	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisone—ulcerative colitis	3.23e-05	0.00997	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Prednisone—ulcerative colitis	3.23e-05	0.00997	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisolone—ulcerative colitis	3.15e-05	0.00973	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Prednisolone—ulcerative colitis	3.15e-05	0.00973	CbGdCrCtD
Minocycline—CYCS—Cellular responses to stress—STAT3—ulcerative colitis	2.68e-05	0.000237	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—RELA—ulcerative colitis	2.68e-05	0.000236	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TGFB1—ulcerative colitis	2.65e-05	0.000234	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.64e-05	0.000233	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—ICAM1—ulcerative colitis	2.64e-05	0.000233	CbGpPWpGaD
Minocycline—CASP1—Immune System—NOD2—ulcerative colitis	2.63e-05	0.000232	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD14—ulcerative colitis	2.61e-05	0.000231	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB1—ulcerative colitis	2.61e-05	0.00023	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL6—ulcerative colitis	2.61e-05	0.00023	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	2.6e-05	0.000229	CbGpPWpGaD
Minocycline—IL1B—Immune System—ITGAL—ulcerative colitis	2.6e-05	0.000229	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—ulcerative colitis	2.58e-05	0.000228	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	2.58e-05	0.000228	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—JAK2—ulcerative colitis	2.55e-05	0.000225	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—ulcerative colitis	2.53e-05	0.000223	CbGpPWpGaD
Minocycline—CASP1—Immune System—VCAM1—ulcerative colitis	2.52e-05	0.000223	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DQA1—ulcerative colitis	2.52e-05	0.000222	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IFNG—ulcerative colitis	2.5e-05	0.000221	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—STAT3—ulcerative colitis	2.48e-05	0.000219	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—ulcerative colitis	2.48e-05	0.000219	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	2.47e-05	0.000218	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—RELA—ulcerative colitis	2.47e-05	0.000218	CbGpPWpGaD
Minocycline—IL1B—Immune System—IRF5—ulcerative colitis	2.47e-05	0.000218	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—ulcerative colitis	2.44e-05	0.000215	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—ulcerative colitis	2.44e-05	0.000215	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	2.43e-05	0.000214	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—ulcerative colitis	2.37e-05	0.000209	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	2.37e-05	0.000209	CbGpPWpGaD
Minocycline—IL1B—Immune System—IRF8—ulcerative colitis	2.36e-05	0.000208	CbGpPWpGaD
Minocycline—IL1B—Immune System—CCR6—ulcerative colitis	2.36e-05	0.000208	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—CDH1—ulcerative colitis	2.34e-05	0.000206	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CALM3—ulcerative colitis	2.34e-05	0.000206	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—ulcerative colitis	2.3e-05	0.000203	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCR1—ulcerative colitis	2.29e-05	0.000202	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	2.29e-05	0.000202	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—JAK2—ulcerative colitis	2.29e-05	0.000202	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	2.27e-05	0.0002	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NFKB1—ulcerative colitis	2.26e-05	0.000199	CbGpPWpGaD
Minocycline—IL1B—Immune System—FCGR2A—ulcerative colitis	2.25e-05	0.000198	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.22e-05	0.000196	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2—ulcerative colitis	2.22e-05	0.000196	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—RELA—ulcerative colitis	2.21e-05	0.000195	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	2.21e-05	0.000195	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	2.2e-05	0.000195	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—ulcerative colitis	2.18e-05	0.000193	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.17e-05	0.000191	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—ulcerative colitis	2.17e-05	0.000191	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS1—ulcerative colitis	2.16e-05	0.000191	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTPN2—ulcerative colitis	2.16e-05	0.00019	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—ulcerative colitis	2.15e-05	0.000189	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.14e-05	0.000189	CbGpPWpGaD
Minocycline—CASP1—Immune System—ADCY5—ulcerative colitis	2.14e-05	0.000188	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—ulcerative colitis	2.1e-05	0.000185	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—ulcerative colitis	2.09e-05	0.000184	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—ulcerative colitis	2.09e-05	0.000184	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	2.08e-05	0.000184	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—ALB—ulcerative colitis	2.06e-05	0.000182	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	2.05e-05	0.000181	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—ulcerative colitis	2.05e-05	0.000181	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—STAT3—ulcerative colitis	2.03e-05	0.000179	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.02e-05	0.000179	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL20—ulcerative colitis	2.01e-05	0.000177	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB1—ulcerative colitis	2.01e-05	0.000177	CbGpPWpGaD
Minocycline—VEGFA—Betamethasone—Hydrocortisone—ulcerative colitis	2e-05	0.00618	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Hydrocortisone—ulcerative colitis	2e-05	0.00618	CbGdCrCtD
Minocycline—MMP9—Spinal Cord Injury—IL6—ulcerative colitis	2e-05	0.000176	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CALM3—ulcerative colitis	1.95e-05	0.000172	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SEL1L—ulcerative colitis	1.93e-05	0.00017	CbGpPWpGaD
Minocycline—CYCS—Levonorgestrel—Hydrocortisone—ulcerative colitis	1.91e-05	0.0059	CbGdCrCtD
Minocycline—CASP3—Signaling Pathways—GNA12—ulcerative colitis	1.89e-05	0.000167	CbGpPWpGaD
Minocycline—VEGFA—Dexamethasone—Methylprednisolone—ulcerative colitis	1.89e-05	0.00583	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Methylprednisolone—ulcerative colitis	1.89e-05	0.00583	CbGdCrCtD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.88e-05	0.000166	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—ulcerative colitis	1.88e-05	0.000166	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—ulcerative colitis	1.87e-05	0.000165	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.87e-05	0.000165	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	1.87e-05	0.000165	CbGpPWpGaD
Minocycline—CASP1—Immune System—CRP—ulcerative colitis	1.87e-05	0.000165	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NFKB1—ulcerative colitis	1.87e-05	0.000165	CbGpPWpGaD
Minocycline—VEGFA—Betamethasone—Dexamethasone—ulcerative colitis	1.86e-05	0.00574	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Betamethasone—ulcerative colitis	1.86e-05	0.00574	CbGdCrCtD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.86e-05	0.000164	CbGpPWpGaD
Minocycline—IL1B—Immune System—CALM3—ulcerative colitis	1.84e-05	0.000162	CbGpPWpGaD
Minocycline—VEGFA—Dexamethasone—Triamcinolone—ulcerative colitis	1.82e-05	0.00561	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Triamcinolone—ulcerative colitis	1.82e-05	0.00561	CbGdCrCtD
Minocycline—IL1B—Immune System—RIPK2—ulcerative colitis	1.81e-05	0.00016	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR4—ulcerative colitis	1.79e-05	0.000158	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCR2—ulcerative colitis	1.79e-05	0.000158	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DRB1—ulcerative colitis	1.79e-05	0.000158	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	1.79e-05	0.000158	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTLA4—ulcerative colitis	1.79e-05	0.000158	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—ulcerative colitis	1.77e-05	0.000156	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—JAK2—ulcerative colitis	1.74e-05	0.000153	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—ulcerative colitis	1.73e-05	0.000153	CbGpPWpGaD
Minocycline—VEGFA—Betamethasone—Prednisone—ulcerative colitis	1.72e-05	0.00532	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Prednisone—ulcerative colitis	1.72e-05	0.00532	CbGdCrCtD
Minocycline—VEGFA—Cellular responses to stress—RELA—ulcerative colitis	1.72e-05	0.000152	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—ulcerative colitis	1.72e-05	0.000152	CbGpPWpGaD
Minocycline—CASP1—Immune System—ICAM1—ulcerative colitis	1.72e-05	0.000152	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD79A—ulcerative colitis	1.7e-05	0.00015	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR6—ulcerative colitis	1.68e-05	0.000149	CbGpPWpGaD
Minocycline—VEGFA—Dexamethasone—Prednisolone—ulcerative colitis	1.68e-05	0.0052	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Prednisolone—ulcerative colitis	1.68e-05	0.0052	CbGdCrCtD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.68e-05	0.000148	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SEL1L—ulcerative colitis	1.67e-05	0.000148	CbGpPWpGaD
Minocycline—IL1B—Immune System—NOD2—ulcerative colitis	1.64e-05	0.000145	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD14—ulcerative colitis	1.63e-05	0.000144	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CXCL8—ulcerative colitis	1.62e-05	0.000143	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAML2—ulcerative colitis	1.6e-05	0.000141	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCR1—ulcerative colitis	1.59e-05	0.00014	CbGpPWpGaD
Minocycline—IL1B—Immune System—VCAM1—ulcerative colitis	1.58e-05	0.000139	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.57e-05	0.000139	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DQA1—ulcerative colitis	1.57e-05	0.000139	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.57e-05	0.000138	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.56e-05	0.000138	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	1.56e-05	0.000137	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.52e-05	0.000134	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDH1—ulcerative colitis	1.52e-05	0.000134	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ABCB1—ulcerative colitis	1.51e-05	0.000134	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—JAK2—ulcerative colitis	1.51e-05	0.000133	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MMP1—ulcerative colitis	1.5e-05	0.000132	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—PPARG—ulcerative colitis	1.48e-05	0.000131	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTGER4—ulcerative colitis	1.48e-05	0.000131	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.46e-05	0.000129	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.46e-05	0.000129	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—NFKB1—ulcerative colitis	1.45e-05	0.000128	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.42e-05	0.000125	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—ulcerative colitis	1.42e-05	0.000125	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ADCY5—ulcerative colitis	1.41e-05	0.000125	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.39e-05	0.000123	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL20—ulcerative colitis	1.39e-05	0.000123	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—ulcerative colitis	1.39e-05	0.000123	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.39e-05	0.000123	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCR1—ulcerative colitis	1.38e-05	0.000122	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GHRL—ulcerative colitis	1.36e-05	0.00012	CbGpPWpGaD
Minocycline—IL1B—Immune System—ADCY5—ulcerative colitis	1.33e-05	0.000118	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS1—ulcerative colitis	1.33e-05	0.000118	CbGpPWpGaD
Minocycline—CASP1—Immune System—JAK2—ulcerative colitis	1.33e-05	0.000117	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.31e-05	0.000116	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CALM3—ulcerative colitis	1.31e-05	0.000116	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNA12—ulcerative colitis	1.31e-05	0.000116	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.31e-05	0.000116	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNG—ulcerative colitis	1.31e-05	0.000115	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—ulcerative colitis	1.31e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—STAT3—ulcerative colitis	1.3e-05	0.000115	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RIPK2—ulcerative colitis	1.29e-05	0.000114	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.29e-05	0.000114	CbGpPWpGaD
Minocycline—CASP1—Immune System—RELA—ulcerative colitis	1.29e-05	0.000114	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PPARG—ulcerative colitis	1.29e-05	0.000114	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.28e-05	0.000113	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—ulcerative colitis	1.26e-05	0.000111	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—ulcerative colitis	1.25e-05	0.00011	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCR2—ulcerative colitis	1.24e-05	0.00011	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—JAK2—ulcerative colitis	1.24e-05	0.000109	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL20—ulcerative colitis	1.21e-05	0.000107	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—RELA—ulcerative colitis	1.2e-05	0.000106	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CALM3—ulcerative colitis	1.2e-05	0.000106	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.19e-05	0.000105	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—ulcerative colitis	1.17e-05	0.000103	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR6—ulcerative colitis	1.17e-05	0.000103	CbGpPWpGaD
Minocycline—IL1B—Immune System—CRP—ulcerative colitis	1.17e-05	0.000103	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—ulcerative colitis	1.17e-05	0.000103	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—ulcerative colitis	1.16e-05	0.000102	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.15e-05	0.000101	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNA12—ulcerative colitis	1.14e-05	0.0001	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ALB—ulcerative colitis	1.14e-05	0.0001	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRB2—ulcerative colitis	1.12e-05	9.91e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR4—ulcerative colitis	1.12e-05	9.88e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DRB1—ulcerative colitis	1.12e-05	9.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAML2—ulcerative colitis	1.11e-05	9.77e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—NFKB1—ulcerative colitis	1.09e-05	9.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCR2—ulcerative colitis	1.08e-05	9.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—JAK2—ulcerative colitis	1.08e-05	9.5e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—ICAM1—ulcerative colitis	1.07e-05	9.47e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.07e-05	9.42e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—JAK2—ulcerative colitis	1.06e-05	9.32e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PPARG—ulcerative colitis	1.05e-05	9.3e-05	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.05e-05	9.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—RELA—ulcerative colitis	1.04e-05	9.2e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTGER4—ulcerative colitis	1.03e-05	9.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR6—ulcerative colitis	1.01e-05	8.95e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NFKB1—ulcerative colitis	1.01e-05	8.94e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.96e-06	8.79e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—ulcerative colitis	9.96e-06	8.79e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—STAT3—ulcerative colitis	9.77e-06	8.62e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAML2—ulcerative colitis	9.62e-06	8.49e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADCY5—ulcerative colitis	9.53e-06	8.41e-05	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.52e-06	8.4e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDH1—ulcerative colitis	9.49e-06	8.37e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—ulcerative colitis	9.48e-06	8.36e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GHRL—ulcerative colitis	9.42e-06	8.31e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ABCB1—ulcerative colitis	9.33e-06	8.24e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—ulcerative colitis	9.22e-06	8.13e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CALM3—ulcerative colitis	9.12e-06	8.05e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—ulcerative colitis	9.12e-06	8.04e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—STAT3—ulcerative colitis	9.11e-06	8.03e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RIPK2—ulcerative colitis	8.99e-06	7.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTGER4—ulcerative colitis	8.93e-06	7.88e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—ulcerative colitis	8.91e-06	7.86e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—ulcerative colitis	8.89e-06	7.84e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NFKB1—ulcerative colitis	8.8e-06	7.76e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ADCY5—ulcerative colitis	8.71e-06	7.68e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—ulcerative colitis	8.44e-06	7.45e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—JAK2—ulcerative colitis	8.32e-06	7.34e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—ulcerative colitis	8.29e-06	7.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GHRL—ulcerative colitis	8.18e-06	7.22e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—ulcerative colitis	8.17e-06	7.21e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—RELA—ulcerative colitis	8.06e-06	7.11e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—ulcerative colitis	8e-06	7.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CALM3—ulcerative colitis	7.92e-06	6.99e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—STAT3—ulcerative colitis	7.9e-06	6.97e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—ulcerative colitis	7.89e-06	6.96e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—ulcerative colitis	7.88e-06	6.95e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RIPK2—ulcerative colitis	7.8e-06	6.88e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB2—ulcerative colitis	7.8e-06	6.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—ulcerative colitis	7.74e-06	6.83e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—ulcerative colitis	7.33e-06	6.47e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—ulcerative colitis	7.26e-06	6.4e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—ulcerative colitis	7.19e-06	6.34e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—ulcerative colitis	6.84e-06	6.04e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—ulcerative colitis	6.83e-06	6.02e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—NFKB1—ulcerative colitis	6.8e-06	6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB2—ulcerative colitis	6.77e-06	5.97e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.68e-06	5.89e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADCY5—ulcerative colitis	6.62e-06	5.84e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARG—ulcerative colitis	6.49e-06	5.73e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—ulcerative colitis	6.36e-06	5.61e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—STAT3—ulcerative colitis	6.11e-06	5.39e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—JAK2—ulcerative colitis	5.94e-06	5.24e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—ulcerative colitis	5.92e-06	5.22e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—ulcerative colitis	5.84e-06	5.15e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RELA—ulcerative colitis	5.76e-06	5.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADCY5—ulcerative colitis	5.75e-06	5.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—ulcerative colitis	5.52e-06	4.87e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL8—ulcerative colitis	5.42e-06	4.79e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—ulcerative colitis	5.18e-06	4.57e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—ulcerative colitis	5.11e-06	4.51e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—ulcerative colitis	4.91e-06	4.33e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NFKB1—ulcerative colitis	4.85e-06	4.28e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STAT3—ulcerative colitis	4.36e-06	3.85e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—ulcerative colitis	4.27e-06	3.76e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—JAK2—ulcerative colitis	4.13e-06	3.64e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—ulcerative colitis	4.04e-06	3.57e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RELA—ulcerative colitis	4e-06	3.53e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL8—ulcerative colitis	3.77e-06	3.32e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—ulcerative colitis	3.6e-06	3.18e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—JAK2—ulcerative colitis	3.58e-06	3.16e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RELA—ulcerative colitis	3.47e-06	3.06e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NFKB1—ulcerative colitis	3.37e-06	2.97e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—ulcerative colitis	3.33e-06	2.94e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL8—ulcerative colitis	3.27e-06	2.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—ulcerative colitis	3.12e-06	2.76e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—ulcerative colitis	3.05e-06	2.69e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT3—ulcerative colitis	3.03e-06	2.67e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—ulcerative colitis	2.96e-06	2.61e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NFKB1—ulcerative colitis	2.93e-06	2.58e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—ulcerative colitis	2.81e-06	2.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT3—ulcerative colitis	2.63e-06	2.32e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—ulcerative colitis	2.44e-06	2.15e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—ulcerative colitis	2.31e-06	2.04e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—ulcerative colitis	2.12e-06	1.87e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—ulcerative colitis	2.01e-06	1.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—ulcerative colitis	1.84e-06	1.62e-05	CbGpPWpGaD
